Want to join the conversation?
$ALXN now expects 2016 research and development expense to be at high end of prior forecast of $650-680MM and selling, general and administrative expense to be at high end of prior $760-790MM outlook. The company still expects interest expense of $100MM, effective tax rate of 7-8% and diluted shares outstanding of 230MM.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)